Among the mutations identified in the test that may be associated with RMS, the CDK4 gene (Case 1) was located at 12q14, encoding the cell cycle regulator CDK4, and its amplification was observed in ARMS, breast cancer, non-small cell lung cancer, and glioblastoma multiforme (21). This evidence concerns the gene CDK4 and alveolar rhabdomyosarcoma.